Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients

BACKGROUND: Despite significant benefits of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR-mutated NSCLC, access remains limited in Thailand and elsewhere. METHODS: Retrospective analysis of patients with locally advanced/recurrent NSCLC and kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Khiewngam, Khantong, Oranratnachai, Songporn, Kamprerasart, Kaettipong, Kunakorntham, Patratorn, Sanvarinda, Pimtip, Trachu, Narumol, Pimsa, Pongput, Wiwitkeyoonwong, Jirapath, Thamrongjirapat, Thanaporn, Dejthevaporn, Thitiya, Sirachainan, Ekaphop, Reungwetwattana, Thanyanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989298/
https://www.ncbi.nlm.nih.gov/pubmed/36895484
http://dx.doi.org/10.3389/fonc.2023.1047644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989298/
https://www.ncbi.nlm.nih.gov/pubmed/36895484
http://dx.doi.org/10.3389/fonc.2023.1047644

Ejemplares similares